GSA Capital Partners LLP trimmed its holdings in shares of COPT Defense Properties (NYSE:CDP – Free Report) by 33.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 65,874 shares of the company’s stock after selling 32,940 shares during the period. GSA Capital Partners LLP owned about 0.06% of COPT Defense Properties worth $1,914,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of COPT Defense Properties during the 2nd quarter valued at approximately $39,371,000. AQR Capital Management LLC increased its position in COPT Defense Properties by 60.0% in the second quarter. AQR Capital Management LLC now owns 1,472,046 shares of the company’s stock worth $40,393,000 after buying an additional 551,863 shares during the last quarter. Alliancebernstein L.P. lifted its position in shares of COPT Defense Properties by 5.9% during the 2nd quarter. Alliancebernstein L.P. now owns 7,241,437 shares of the company’s stock valued at $199,719,000 after buying an additional 406,617 shares during the last quarter. Fort Washington Investment Advisors Inc. OH increased its holdings in COPT Defense Properties by 38.8% in the 3rd quarter. Fort Washington Investment Advisors Inc. OH now owns 1,001,514 shares of the company’s stock worth $29,104,000 after acquiring an additional 279,790 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in COPT Defense Properties by 7.7% during the third quarter. JPMorgan Chase & Co. now owns 3,566,073 shares of the company’s stock valued at $103,630,000 after purchasing an additional 253,558 shares during the last quarter.
COPT Defense Properties Trading Down 0.7%
Shares of COPT Defense Properties stock opened at $31.55 on Tuesday. The company has a 50 day simple moving average of $29.79 and a two-hundred day simple moving average of $29.28. The firm has a market cap of $3.57 billion, a PE ratio of 23.37 and a beta of 0.86. COPT Defense Properties has a 1 year low of $23.92 and a 1 year high of $32.78. The company has a debt-to-equity ratio of 1.77, a current ratio of 3.95 and a quick ratio of 2.34.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on CDP shares. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of COPT Defense Properties in a report on Wednesday, January 21st. Evercore reiterated an “outperform” rating on shares of COPT Defense Properties in a research note on Friday, February 6th. Jefferies Financial Group lifted their target price on COPT Defense Properties from $33.00 to $34.00 and gave the company a “buy” rating in a report on Tuesday, January 27th. Wells Fargo & Company increased their price target on shares of COPT Defense Properties from $30.00 to $33.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, Cantor Fitzgerald raised their price objective on shares of COPT Defense Properties from $33.00 to $37.00 and gave the company an “overweight” rating in a research report on Monday, February 9th. Six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $33.63.
View Our Latest Stock Analysis on COPT Defense Properties
About COPT Defense Properties
COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.
The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.
Recommended Stories
- Five stocks we like better than COPT Defense Properties
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for COPT Defense Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COPT Defense Properties and related companies with MarketBeat.com's FREE daily email newsletter.
